Moderna CFO Jorge Gomez departs amid Dentsply Sirona investigation; David Meline returns as CFO

Moderna, Inc.

Jorge Gomez terminated as CFO effective May 10, 2022, after former employer Dentsply Sirona disclosed an internal investigation.
David Meline, previously CFO from June 2020 to July 2021, resumes role effective May 11, 2022.
Gomez receives 12 months' salary ($700,000) and COBRA coverage; forfeits signing bonus, relocation, bonus, and new hire equity.
Meline retains annual salary of $700,000, 90% bonus target, and full vesting of 2022 equity awards previously set to forfeit on retirement.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

David Meline

Chief Financial Officer

MRNA · Moderna, Inc.

Effective: 2022-05-11
Filed: May 11, 2022, 7:59 PM ET

David Meline, the Company’s recently retired Chief Financial Officer, will continue as Chief Financial Officer, effective May 11, 2022.

Departed

Jorge Gomez

Chief Financial Officer

MRNA · Moderna, Inc.

Effective: 2022-05-10
Successor: David Meline
Filed: May 11, 2022, 7:59 PM ET

On May 10, 2022, Jorge Gomez departed, effective immediately, from the role of Chief Financial Officer of Moderna, Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David Meline was appointed as Chief Financial Officer at Moderna, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

David Meline, the Company’s recently retired Chief Financial Officer, will continue as Chief Financial Officer, effective May 11, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jorge Gomez departed as Chief Financial Officer at Moderna, Inc..

Action: departed
Role: Chief Financial Officer

Exact text from the filing

On May 10, 2022, Jorge Gomez departed, effective immediately, from the role of Chief Financial Officer of Moderna, Inc.

View on SEC.gov

Moderna, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-146929

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.